Samsung Uses Galaxy Watch Tech for Medical Research
三星利用 Galaxy Watch 技術進行醫學研究
更新於: 2026年6月24日 上午08:30
Samsung is transforming the Galaxy Watch from a standard fitness tracker into a powerful medical research instrument.
三星正將 Galaxy Watch 從一款標準的健康追蹤器，轉型為強大的醫學研究儀器。
By moving toward 'decentralized clinical trials,' the company is helping researchers gather real-world data outside of traditional hospital settings.
透過推動「去中心化臨床試驗」，該公司正協助研究人員在傳統醫院環境外收集真實世界的數據。
This shift allows for continuous, longitudinal tracking of health markers like heart rate, sleep patterns, and physical activity, providing a more accurate picture of a patient's health.
這項轉變能實現對心率、睡眠模式及身體活動等健康指標的持續性、縱向追蹤，從而提供更精確的患者健康畫像。
Strategic partnerships are central to this initiative.
策略夥伴關係是此項計畫的核心。
Collaborations with Alcedis aim to evaluate the safety and efficacy of new drugs, while the partnership with Verily integrates watch data into advanced AI-driven analysis platforms.
與 Alcedis 的合作旨在評估新藥的安全性與療效，而與 Verily 的合作則將智慧手錶的數據整合進進階 AI 驅動的分析平台。
Furthermore, Samsung is working with prestigious institutions like Stanford University and Massachusetts General Hospital to study conditions ranging from sleep apnea to muscle health.
此外，三星也正與史丹佛大學及麻省總醫院等頂尖機構合作，研究從睡眠呼吸暫停到肌肉健康等各種病症。
By bridging the gap between wearable technology and hospital records through their 'Connected Care' ecosystem, Samsung is reducing the burden on patients and improving clinical trial participation.
透過其「Connected Care」生態系統，將穿戴式裝置技術與醫院病歷連結，三星正在減輕患者負擔並提升臨床試驗的參與度。
With FDA-cleared features already in place, the Galaxy Watch is becoming a vital tool for the future of personalized medicine and preventive healthcare.
藉助現已獲得 FDA 認證的功能，Galaxy Watch 正成為未來個人化醫學與預防性醫療的關鍵工具。
